Roles of intrinsic and acquired resistance determinants in multidrug-resistant clinical Pseudomonas aeruginosa in Bangladesh

被引:3
|
作者
Anjum, Hasnain [1 ]
Arefin, Md. Shamsul [1 ]
Jahan, Nusrat [2 ]
Oishee, Mumtarin Jannat [1 ]
Nahar, Shamsun [1 ]
Islam, Salequl [1 ]
Banerjee, Sudeshna [3 ]
Sinha, Susmita [4 ]
Kumar, Santosh [5 ]
Haque, Mainul [6 ,7 ]
Rahman, M. Hasibur [1 ]
机构
[1] Jahangirnagar Univ, Dept Microbiol, Dhaka 1342, Bangladesh
[2] Jahangirnagar Univ, Dept Biochem & Mol Biol, Dhaka 1342, Bangladesh
[3] Shri Anand Coll Nursing, Dept Med & Surg Nursing, Rajkot, Gujarat, India
[4] Khulna City Med Coll & Hosp, Dept Physiol, KDA Ave, Khulna, Bangladesh
[5] Karnavati Univ, Karnavati Sch Dent, Dept Periodontol, Gandhinagar, Gujarat, India
[6] Univ Pertahanan Nasl Malaysia, Natl Def Univ Malaysia, Fac Med & Defence Hlth, Kem Perdana Sungai Besi, Kuala Lumpur 57000, Malaysia
[7] Karnavati Univ, Karnavati Sch Dent, Dept Sci Res Ctr KSRC, Gandhinagar 382422, Gujarat, India
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2023年 / 22卷 / 03期
关键词
Pseudomonas aeruginosa; ESKAPE; OprD; Innate and Attained Resistance; Multidrug-resistant; Clinical Outcome; Bangladesh; SPECTRUM BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; ESKAPE PATHOGENS; DRUG-RESISTANCE; OUTER-MEMBRANE; SUSCEPTIBILITY PATTERN; RIBOSOMAL DNA; EFFLUX PUMPS;
D O I
10.3329/bjms.v22i3.66960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pseudomonas aeruginosa is an ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, P. aeruginosa, and Enterobacter spp.) pathogen and one of the leading etiologies in multiple nosocomial infections. Treatment of P. aeruginosa is becoming increasingly difficult due to its ever-increasing antibiotic resistance trends. This study investigated clinical multidrug resistance (MDR) P. aeruginosa (MDR-PA), their intrinsic resistance determinants, including the presence of chromosomal AmpC fl-lactamase (Ampicillinase), decreased expression of outer membrane porin protein OprD and selected acquired fl-lactamase resistance genes. Methods: Out of 238 clinical specimens, including urines from urinary tract-infected patients, wound swabs, burn swabs, and catheter aspirates, were collected from two major hospitals in Savar, Dhaka, Bangladesh. Samples were inoculated with Cetrimide agar to isolate presumptive P. aeruginosa. Bacteria were identified by cultural, biochemical characterization, 16S rDNA sequencing, and phylogenetic analysis. Virulence-associated genes of P. aeruginosa, namely, toxA, lasB, and plcH, were identified by polymerase chain reaction (PCR). Antibiotic susceptibilities of the isolates were investigated against ten antibiotics belonging to seven groups by disc-diffusion method followed by a selected minimum inhibitory concentration (MIC) assay. Phenotypic expression of Metallo-fl-lactamases (MBLs) production was checked by the double disc synergistic test selectively among the imipenem-resistant isolates. Acquisition of fl-lactam resistance trait was examined by PCR detection of bla-genes variants. Mutational loss of the OprD was analyzed by PCR to investigate intrinsic resistance determinants. Phenotypic overexpression of chromosomal AmpC was assayed with the identification of the AmpC gene by PCR. The expression level of OprD was assessed by real-time quantitative PCR (RT-qPCR). Results: Fifty-three P. aeruginosa was identified, with an overall isolation of 22.3% (53/238), where urine remains the most prevalent source. Virulence genes toxA, lasB, and plcH were identified in the isolates of 92.4%, 96.2%, and 94.3%. The highest phenotypic antimicrobial resistance was observed against ampicillin and ceftriaxone (100%), followed by cefotaxime (96%), tetracycline (89%), azithromycin (72%), imipenem (31%), ciprofloxacin (29%), levofloxacin (29%), gentamycin (27%) and ceftazidime (14%). The antibiogram pattern revealed 85% of isolates as multidrug-resistant, while 12% were considered extensively drug-resistant (XDR)-P. aeruginosa. The carriage of fl-lactamase genes blaTEM, blaSHV, and blaOXA was detected in 4%, 2%, and 2% cephalosporin-resistant isolates, respectively. Double disc synergistic test revealed 87% of imipenem-resistant isolates expressing MBL-mediated resistance phenomenon. All seven ceftazidime-resistant isolates showed the presence of the AmpC gene with phenotypic overproduction of the AmpC enzyme, indicating AmpC-mediated ceftazidime resistance. Mutational loss of OprD was observed in 12% of phenotypically multidrug-resistant isolates, and RT-qPCR analysis revealed reduced expression of OprD porin protein at various levels in the outer membrane of multidrug-resistant isolates. Conclusions: This study depicts the high prevalence of MDR-PA in clinical specimens in Bangladesh. The identified intrinsic and acquired antimicrobial resistance determinants play synergistic roles in emerging MDR-PA.
引用
收藏
页码:489 / 507
页数:19
相关论文
共 50 条
  • [11] Virulence Characteristics and an Action Mode of Antibiotic Resistance in Multidrug-Resistant Pseudomonas aeruginosa
    Hwang, Wontae
    Yoon, Sang Sun
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [12] Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy
    Zavascki, Alexandre P.
    Carvalhaes, Cecilia G.
    Picao, Renata C.
    Gales, Ana C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (01) : 71 - 93
  • [13] Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance
    Haidar, Ghady
    Philips, Nathan J.
    Shields, Ryan K.
    Snyder, Daniel
    Cheng, Shaoji
    Potoski, Brian A.
    Doi, Yohei
    Hao, Binghua
    Press, Ellen G.
    Cooper, Vaughn S.
    Clancy, Cornelius J.
    Hong Nguyen, M.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : 110 - 120
  • [14] Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa
    Sabuda, Deana M.
    Laupland, Kevin
    Pitout, Johann
    Dalton, Bruce
    Rabin, Harvey
    Louie, Thomas
    Conly, John
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2008, 19 (06): : 413 - 418
  • [15] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Coyne, Ashlan J. Kunz
    El Ghali, Amer
    Holger, Dana
    Rebold, Nicholas
    Rybak, Michael J.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 661 - 682
  • [16] Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
    Ashlan J. Kunz Coyne
    Amer El Ghali
    Dana Holger
    Nicholas Rebold
    Michael J. Rybak
    Infectious Diseases and Therapy, 2022, 11 : 661 - 682
  • [17] Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
    Miyoshi-Akiyama, Tohru
    Tada, Tatsuya
    Ohmagari, Norio
    Nguyen Viet Hung
    Tharavichitkul, Prasit
    Pokhrel, Bharat Mani
    Gniadkowski, Marek
    Shimojima, Masahiro
    Kirikae, Teruo
    GENOME BIOLOGY AND EVOLUTION, 2017, 9 (12): : 3238 - 3245
  • [18] Multidrug-Resistant Pseudomonas aeruginosa Keratitis Risk Factors, Clinical Characteristics, and Outcomes
    Vazirani, Jayesh
    Wurity, Siva
    Ali, Md Hasnat
    OPHTHALMOLOGY, 2015, 122 (10) : 2110 - 2114
  • [19] Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections
    Holger, Dana
    Kebriaei, Razieh
    Morrisette, Taylor
    Lev, Katherine
    Alexander, Jose
    Rybak, Michael
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [20] Antibiotic combination therapy and clinical outcome for multidrug-resistant Pseudomonas aeruginosa infections
    Nakamura, I.
    Yamaguchi, T.
    Shimizu, H.
    Fukushima, S.
    Mizuno, Y.
    Matsumoto, T.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S146 - S146